Renal Disease

A unique and comprehensive collection of translational models to study renal disease

cvmd-magnifyglass.png

"CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing problems in oncology, cardiovascular, and metabolic disease.

Leveraging our industry expertise, CrownBio's global resources help customers answer the most challenging questions about human biology. We begin with the end insight to help you achieve your goals"

Dr Jean-Pierre Wery
CEO, Crown Bioscience Inc.

CrownBio's Renal Disease Research Platform Provides Unique Models and Cutting-Edge Technologies

Renal disease exists in many forms, and as such requires a wide variety of preclinical research models.

CrownBio’s Renal Disease Research Platform provides a range of human disease-relevant rodent and NHP models including models of genetic disorders of the kidney, such as polycystic kidney disease (PKD), models of induced kidney disease, as well as models with kidney conditions arising from late stage diabetes complications e.g. diabetic nephropathy.

PKD is currently incurable, and diabetic nephropathy is the leading cause of dialysis and kidney transplant in developed countries, therefore appropriate preclinical models are needed for both conditions, as well as for the wide range of other kidney diseases, to both develop and improve treatments.

Explore Our Portfolio of Models and Study Endpoints for Renal Disease

CrownBio provides renal disease models of:

Each model has a range of validated endpoints to meet research needs, including:

  • Body weight
  • Plasma BUN, ALT, AST, bilirubin, and creatinine measurement
  • Urinary albumin measurement,
  • Kidney weights and histology for fibrosis or cyst volume determination

Contact us today to discuss your renal disease project needs and to experience the value of our expert service.